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LongevityDietary restriction (DR) attenuates many detrimental effects of aging and consequently promotes health and
increases longevity across organisms. While over the last 15 years extensive research has been devoted towards
understanding the biology of aging, the precise mechanistic aspects of DR are yet to be settled. Abundant exper-
imental evidence indicates that the DR effect on stimulating health impinges several metabolic and stress-
resistance pathways. Downstream effects of these pathways include a reduction in cellular damage induced by
oxidative stress, enhanced efﬁciency of mitochondrial functions and maintenance of mitochondrial dynamics
and quality control, thereby attenuating age-related declines in mitochondrial function. However, the literature
also accumulates conﬂicting evidence regarding how DR ameliorates mitochondrial performance and whether
that is enough to slow age-dependent cellular and organismal deterioration. Here,wewill summarize the current
knowledge about how and to which extent the inﬂuence of different DR regimes on mitochondrial biogenesis
and function contribute to postpone the detrimental effects of aging on healthspan and lifespan. This article is
part of a Special Issue entitled: Mitochondrial Dysfunction in Aging.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Altered mitochondrial metabolism is a hallmark of aging [1]. Re-
duced respiratory capacity and increased oxidative stress associated
with age have been reported in an array of tissues, including muscle
and several brain regions [1]. The mitochondrial/free radical theory of
aging explains many aspects of cell and organismal aging. This theory
proposes that mitochondrial energy production decline and mitochon-
drial reactive oxygen species (ROS)-induced damage are the major
causes of aging [2]. Although this is a longstanding theory, evidence
supporting and contradicting its postulates, gathered from studies on
diverse model organisms, accumulate in the literature [3–6]. Overall,
these studies suggest that although oxidative damage is an important
contributor, there is more to aging than damage mediated by ROS. On
the other hand, preservation of mitochondrial functions and enhance-
ment of mitochondrial biogenesis are critical components of several
mechanisms promoting health and lifespan extension that are
conserved from yeast to mammals [7–9].ndrial Dysfunction in Aging.
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MSB 2067, 1600 NW 10th Ave.,
5 243 7404.
entos).Research efforts have been devoted to strategies for longevity exten-
sion, regarded as a retardation of biological aging. Although longevity
extension strategies will not eliminate aging-related diseases, they are
expected to postpone their age of onset, thus contributing to the objec-
tive of extending healthspan [10]. Calorie restriction (CR), whichusually
refers to a 20–40% reduction in calorie intake without malnutrition, is
the most robust environmental intervention that slows aging and
extends lifespan in yeast, worms, fruit ﬂies, rodents, and perhaps also
in primates [10–13], through largely conserved mechanisms.
Studies to understand the molecular mechanisms of CR-mediated
longevity in simple research models, such as the yeast Saccharomyces
cerevisiae, have allowed for the identiﬁcation of several longevity
genes and pathways. In yeast, CR down-regulates the conserved signal-
ing pathways Ras/cAMP/PKA, TOR (target of rapamycin), and its major
target the serine/threonine protein kinase Sch9, all of which integrate
nutrient and other environmental cues to regulate cell growth, division,
and lifespan [12]. Deletion of RAS2, TOR1 or SCH9 enhances cellular
protection against thermal and oxidative stresses and extends yeast
chronological lifespan (CLS) [14]. Inhibition of these pathways con-
verges on the activation of stress resistance transcription factors that
positively regulate the expression of cell protection systems; e.g.
chaperones to combat protein misfolding, free radical scavengers such
as catalase and mitochondrial superoxide dismutase (SOD2), and accu-
mulation of store nutrients (trehalose and glycogen in yeast cells). The
key components of these pathways also regulate stress resistance
and lifespan in higher eukaryotes [15]. For example, both serine/
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kinase), homologues of yeast SCH9, regulate lifespan in higher eukary-
otes and inhibition of TOR/S6K signaling extends lifespan in worms,
ﬂies, andmice [16,17]. Also, mice deﬁcient in elements of the RAS path-
way have extended health- and lifespan [18]. Together, these studies
have highlighted an important role of nutrient-sensing pathways in
lifespan modulation and CR-induced lifespan extension, suggesting a
common evolutionary origin of aging regulation [14].
The longevity pathways play an important role in the regulation of
mitochondrial biogenesis and/or function in yeast and higher eukary-
otes including mammals [19,20]. For example, deletion of the TOR1
gene extends yeast CLS in part by increasing mitochondrial mass and
respiration [19] and by promoting adaptive mitochondrial ROS signal-
ing [21]. The Ras/cAMP/PKA pathway senses excessive ROS to signal to
theHap2,3,4,5 transcriptional systemanddown-regulatesmitochondri-
al biogenesis [22]. Also, in mammals, modulation of mitochondrial bio-
genesis and metabolism through the TOR, Akt1, and Ras pathways
involves the peroxisome proliferator activated receptor gamma tran-
scriptional coactivator-1α (PGC-1α) [20]. PGC-1α is a master regulator
of mitochondrial biogenesis that coactivates the nuclear respiratory
factors (NRF-1 and NRF-2), which induce the transcription of genes
involved in mitochondrial biogenesis.
Numerous recent studies on model organisms and even in humans
suggest that the health-promoting effect of CR interventions can be
achieved by decreases in speciﬁc dietary components. Interventions
such as protein restriction (PR), methionine restriction, and alternate
day fasting while maintaining overall calorie intake, have outcomes
similar to that observed following a CR diet. It is also becoming evident
that the balance of nutrients such as carbohydrates, proteins, amino
acids, fats, and minerals may play an essential role in regulating both
lifespan and healthspan. Dietary restriction (DR) studies in yeast, fruit
ﬂies, rodents, and primates are beginning to clarify the dietary factor/s
that cause/s the beneﬁcial changes and the role of mitochondrial
function in the mechanism/s involved.
The effects of DR on aging and healthspan have been covered by
many recent reviews, focusing on simplemodel organisms ormammals
[15,23,24], mostly on calorie restriction (CR) and less frequently on pro-
tein and amino acid restriction [15,25]. In thismanuscript, wewill cover
the information gained from exploiting yeast models of aging and will
subsequently focus on studies performed in higher organisms to
summarize the current knowledge about the inﬂuence of different DR
regimes on mitochondrial biogenesis and function, the pathways
involved, and the extent to which maintaining mitochondrial health
through DR contributes to postpone the detrimental effects of aging
on health- and lifespan.2. Dietary Restriction, Mitochondria, Aging and Longevity in the
Yeast Saccharomyces Cerevisiae
2.1. Mitochondrial determinants of yeast longevity
The facultative aerobe/anaerobe metabolism of the yeast Saccharo-
myces cerevisiaemakes this organism a good model for mitochondrial
studies. Over the last three decades, S. cerevisiaemodels of aging have
contributed to the discovery of conserved longevity factors that modu-
late aging in mammals [26,27]. Two models of aging, the replicative
lifespan (RLS) model and the chronological lifespan (CLS) model, have
been established in this organism. RLS is deﬁned as the number of
asymmetric mitotic divisions a mother cell can undergo prior to cell
cycle arrest. This yeast mother-cell-speciﬁc aging constitutes a model
of replicative aging as it occurs in ﬁbroblasts, lymphocytes, or stem
cell populations of higher eukaryotes [26–28]. CLS, deﬁned as the capac-
ity of postdiauxic, stationary (G0) cultures to maintain viability over
time, is, on the other hand, a model for the aging process of postmitotic
cells such as mature neurons and muscle cells [27,29].In yeast, mitochondrial function is important for both replicative and
chronological lifespan, as mitochondrial oxidative phosphorylation
(OXPHOS) function deteriorates and mitochondrial ROS generation
ampliﬁes with increasing age [29,30]. During replicative aging, the
changes the mother cell undergoes include an increased generation
time, increased size, declined mating ability, nucleolar and mitochon-
drial fragmentation, and the accumulation of both extra-chromosomal
rDNA circles (ERCs) and oxidatively damaged proteins [31,32]. The ef-
fect of mitochondrial dysfunction on RLS may be not fully dependent
of the OXPHOS capacity of the organelle, since the literature accumu-
lates examples of mutations limiting respiration that either curtail or
prolong RLS [30]. However, RLS is extended by enhancement of mito-
chondrial biogenesis [33], and mitochondrial function links RLS and
CLS [34]. Additional parameters, such as proper mitochondrial segrega-
tion and inheritance [33], prevention of mitochondrial proteotoxic
stress [35,36], and maintenance of proper nuclear-mitochondrial com-
munication through activation of mitochondrial retrograde signaling
pathways [37] are important regulators of RLS. For example, a mecha-
nism exists for retaining “less ﬁt” mitochondria within the mother
cell, thus preventing their transmission into the daughter cell [38].
Thanks to asymmetrical protein inheritance, daughter cells are able to
eliminate ROS after completion of cytokinesis [39], ensuring that the
new cell is born with a full replicative potential. Additionally, special
mention also go to mitochondrial retrograde responses that have
emerged as important players in aging and longevity [40], further
emphasizing the importance of metabolic control in determining
these processes. In yeast, the ﬁrst described mitochondria-to-nucleus
retrograde (RTG) pathway senses decline in mitochondrial membrane
potential and initiates a transcriptional response to compensate for
mitochondrial dysfunction by reconﬁguring metabolism [37,41,42].
The RTG response increases the expression of genes involved in
anaplerotic pathways that supply acetyl-CoA and citrate to mitochon-
dria, including genes involved in peroxisomal biogenesis and fatty acidβ-oxidation [37]. The TCA cycle is disrupted in respiratory-deﬁcient
yeast, and peroxisomal anaplerotic contributions become critical to
maintenance of an adequate pool ofα-ketoglutarate, essential for cellu-
lar redox maintenance and the generation of glutamate, a basic source
of nitrogen [37]. Three proteins, Rtg1, Rtg2, and Rtg3, are required for
the retrograde response in yeast [43,44]. Rtg2 transduces themitochon-
drial dysfunction signal, speciﬁcally the loss ofmitochondrialmembrane
potential [42], and promotes the formation of the active heterodimeric
Rtg1-Rtg3 transcription factor that translocates to the nucleus and
binds to the retrograde response element in the promoters of retrograde
response genes [37,43,44]. Activation of the RTG pathway has been
shown to extend RLS in certain conditions [42]. Other organelles also
inﬂuence mitochondrial ﬁtness and overall replicative aging [45]. Vacu-
olar acidiﬁcation decreases with replicative age and this parameter
correlates with loss of mitochondrial membrane potential [45]. Thus,
multiple factors inﬂuence mitochondrial quality control, ultimately af-
fecting RLS.
Chronologically aging cells require mitochondrial respiration along
their lifespan [46]. For CLS studies, yeast cells are usually aged in
media containing 2% glucose. Under these conditions, cells divide expo-
nentially producing energy preferentially by fermentation while respi-
ration is repressed in a glucose-concentration-dependent manner. As
glucose is being consumed, growth slows down and the diauxic shift
occurs, which involves a shift from fermentation to respiration, the
activation of stress resistancemechanisms, and the accumulation of nu-
trient stores (glycogen and trehalose) to be used later in the stationary
phase inwhich themetabolic rate is signiﬁcantly reduced.Mitochondri-
al respiration during exponential growth is essential for strains to
achieve a standard wild-type CLS [47–49]. However, we have shown
that yeast cells have a large reserve respiratory capacity to sustain CLS,
as respiration only limits CLS when depleted below ~40% of wild-type
threshold [7]. Strains that respire below the threshold during growth
have extremely poor respiratory capacity in the stationary phase,
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inefﬁcient fermentation pathway, and have very short CLS [7]. Respira-
tory defects are less detrimental when produced only in the stationary
phase, once yeast have accumulated nutrient stores during growth
and undergone their diauxic shift metabolic remodeling [7]. Several
cell-intrinsic factors are involved in the requirement for a certain level
of respiratory capacity to maintain wild-type CLS. First, aerobic energy
production is required for the efﬁcient function of anti-oxidative stress
systems and for proper synthesis and accumulation of reserve carbohy-
drates, particularly trehalose. In fact, trehalose supplementation to the
growth media enhances the stress-resistance capacity of respiratory
deﬁcient strains and signiﬁcantly extends their CLS [7]. Consistently, a
recent report has shown that deletions of genes in the trehalose biosyn-
thetic pathway, including tsl1, tps3, and ath1 that increase intracellular
trehalose concentration during growth and postdiauxic shift, extend
CLS even in CR conditions by modulating cellular proteostasis through-
out lifespan [50]. Mitochondrial respiration also controls aging and lon-
gevity through maintenance of mitochondrial membrane potential
since activation of the RTG pathway is necessary for wild-type CLS
[51]. Furthermore,mitochondrial respiration controls aging and longev-
ity through generation of ROS, which represents another kind of
mitochondrial retrograde response. Although mitochondrial ROS are
known to limit the long-term survival of yeast cells during CLS and
can have a detrimental effect during aging in higher eukaryotes, they
can also act as signaling molecules with hormetic effects on longevity
[5,21]. For example, we have shown that, in addition to increased
coupled respiration, TOR1 mutant strains also have enhanced ROS
production during exponential growth, which provides an adaptive
signal that contributes to increase cell protection systems and extends
CLS [21]. The CLS of yeast strains can be curtailed by increased mito-
chondrial SOD2 levels, or can be signiﬁcantly extended by additional
exogenous ROS exclusively during growth, since ROS are harmful dur-
ing stationary phase [7,21].
2.2. Mitochondria-mediated effects of CR in yeast longevity
Although the determinants of CLS and RLS in yeast seem to be
both overlapping and distinct [27], one of the features that are
shared between the two aging models is a robust lifespan extension
in response to dietary restriction. The most popular form of DR is cal-
orie restriction, usually mimicked in yeast by reducing the glucose
concentration in the media from 2% to 0.5% or lower, although re-
striction of one or several amino acids also extends both lifespans.
The mechanisms responsible for the lifespan extension induced by
CR are not yet fully understood but all models include a relevant
role for mitochondrial functions.
2.2.1. Replicative lifespan
Early studies suggested that CR extends replicative lifespan due to
enhanced mitochondrial respiration under low glucose levels [33].
Supporting this hypothesis, overexpression of HAP4, the catalytic
subunit of the Hap2,3,4,5 transcriptional system that positively controls
mitochondrial biogenesis and consequently shifts metabolism towards
respiration, extends RLS [33]. Both interventions, CR and HAP4 overex-
pression, induce an increase in NAD+/NADH ratio, which serves to acti-
vate the NAD-dependent histone deacetylase Sir2 [52], which mediates
rDNA silencing, reducing the generation of toxic rDNA circles. Consis-
tent with this model, Sir2-dependent RLS extension can be achieved
by overexpression of two components of the mitochondrial malate-
aspartate NADH shuttle, malate dehydrogenase (Mdh1) and aspartate
amino transferase (Aat1) [53]. Since this effect does not synergize
with CR-induced lifespan extension, it was suggested that CR may
extend lifespan by activating components of the mitochondrial NADH
shuttles [53]. An alternative model suggested that CR may act through
inhibition of the TOR pathway and the transcription factors Msn2/4, to
increase the levels of the nicotinamidase Pnc1, thus activating Sir2 bydecreasing the levels of its inhibitor, nicotinamide [54,55]. However,
the importance of Sir2 in lifespan extension by CR has been questioned
since it is not reproducible in all yeast backgrounds [56]. Furthermore,
comparison of CR effects on different yeast strains has indicated that
respiration or Sir2 are not absolutely required for at least some the
replicative longevity beneﬁts of CR and that nicotinamide inhibits RLS
extension by DR through a Sir2-independent mechanism [57]. Some
of these experiments used either CR of 0.5% glucose, or extreme CR of
0.05% glucose, which could explain some of the differences in the results
obtained [58]. However, more recent studies showed that the levels of
rDNA silencing are not affected by CR; rather, CR reduces the level of
internal DNA recombination at rDNA loci, in a Sir2-independentmanner
[59]. Although the CR mechanism is not fully clariﬁed, there is at least
general agreement that respiration confers full extension capacity by
CR, and that, as explained in the previous section, some respiration-
independent mitochondrial functions related to organelle quality con-
trol are essential for RLS extension by CR.
2.2.2. Chronological lifespan
CR modeled by growing yeast cells in 0.5% glucose, extends yeast
CLS through a mechanism that involves: (i) inhibition of nutrient-
responsive kinases such as the target of rapamycin (TOR-Sch9) and
the Ras2–cAMP–PKA pathway [12,15], (ii) general enhancement of
stress-resistance mechanisms, (iii) maximization of ROS adaptive
signaling, (iv) increased respiration during growth, (v) metabolic re-
modeling following the diauxic shift, and (vi) dramatic metabolic rate
reduction in the stationary phase allowing for slow consumption of
stored nutrients. Genetic interventions, such as deletion of tor1 (homo-
log of the mechanistic target of rapamycin -mTOR), sch9 (homolog of
the ribosomal S6 kinase), or ras2, act as DR mimetics [56,60]. These
mutations seem to work through the same mechanisms as CR, but
their effect on CLS is not as robust as CR itself. All of these interventions
induce an increase in mitochondrial respiration and ROS adaptive sig-
naling during growth, involving increased superoxide and hydrogen
peroxide levels [61,62]. However, while CR induces a Hap2,3,4,5
complex-mediated enhancement of mitochondrial biogenesis, TOR1
signaling-deﬁcient strains have a higher density of mitochondrial
respiratory-chain enzymes per organelle without global enhancement
of mitochondrial biogenesis [19,21]. Independently, mitochondrial res-
piration is essential for CLS extension by CR or tor1Δ, since their effect
is abrogated by genetic and pharmacological interventions that elimi-
nate respiration during growth [7]. CR leads to a 30% higher respiratory
rate during growth [7,63]. However, although CR-treated strains reach
the stationary phase at a time similar to non-restricted cells, they barely
respire once they reach this point [7]. This observation suggests that the
metabolic remodeling program that begins with the entry of CR cells
into the stationary phase alters the requirement of respiration during
chronological aging. Consistent with this effect, pharmacological inhibi-
tion of respiration in CR cultures during the stationary phase does not
affect CLS [7]. While both CR and tor1Δ enhance mitochondrial respira-
tion during growth, their effect on stationary phase respiration is differ-
ent. Contrary to what is seen during CR-treatment, tor1Δ strains are
sensitive to OXPHOS inhibitors when supplemented in the stationary
phase. Thus, CR-treated cells are less dependent onmitochondrial respi-
ration during the stationary phase than are tor1Δ cells [7], consistent
with the notion that inhibition of TOR1 is just one of the mechanisms
contributing to the CR effect on CLS.
Notably, the requirement of respiration for CR-induced CLS follows a
threshold pattern. Yeast that respire above a ~40%-of-wild-type thresh-
old during growth can beneﬁt from either CR- or tor1Δ-induced CLS ex-
tension. However, contrary to the effect on RLS, increased respiration
during growth (e.g. by HAP4-overexpression) is not sufﬁcient to extend
CLS in strains that havemaximized the CLS extension achievable by ROS
signaling [7]. The relationship between respiration, ROS, and CLS is,
however, complex. A comparison of yeast strains with different genetic
backgrounds suggested a correlation between respiratory capacity,
Fig. 1. Interventions that beneﬁcially affect longevity within the two yeast models of aging. Studies in S. cerevisiae have identiﬁed conserved longevity pathways, andmay be important in
elucidating how CR may differentially effect speciﬁc tissues through the CLS model, which mirrors the aging process of post-mitotic cells such as neurons and muscle cells, and the RLS
model, which mirrors the aging of dividing cells in higher eukaryotes such as ﬁbroblasts, lymphocytes, and stem cells. In this ﬁgure, the speciﬁc, as well as shared, interventions that
lead to longevity extension in these two pathways are outlined. Interventions that affect yeast longevity in the CLS model are further divided by the phase of CLS in which they must
be present to have beneﬁcial effect.
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respiration and ROS production have a longer CLS, which is curtailed by
increased SOD2 levels, whereas strains with low respiration and ROS
production have a shorter CLS and can signiﬁcantly beneﬁt from addi-
tional exogenous ROS or tor1Δ-induced endogenous ROS [21]. Our
data support amodel inwhichROS signaling and the respiratory thresh-
olds are complementary aging modulators that utilize two distinct
mechanisms to achieve the same adaptive endpoint: increased stress
resistance, efﬁcient use of energy stores, and probably other beneﬁcial
effects in the stationary phase, all of which extend CLS.
2.3. Mitochondrial function links replicative and chronological lifespan and
their extension by CR
Yeast RLS and CLS are different in nature. However, some common
basic mechanisms inﬂuence the aging process generally (Fig. 1) since
chronological aging has been shown to reduce RLS [34]. As explained
earlier, both aging paradigms are associated with increased accumula-
tion of mitochondrial damage and oxidatively damaged/aggregated
proteins [26]. A recent study showed that DR during CLS maintains
phenotypically “younger” cells and delays the reduction in subsequent
RLS up to 23 days of chronological age [34]. Looking for a mechanism,
the authors found that among the viable portion of the control popula-
tion aged 26 days, individual cells with the longest subsequent RLS had
the lowest mitochondrial membrane potential. These observations
are in agreement with our data on the barely detectable respiration of
CR-treated cells during stationary phase [7]. Additional pathways
seem to converge at or depend on mitochondrial functions. For exam-
ple, CR also induces autophagy via inhibition of mTOR [64], which
would be expected to facilitate degradation of damaged mitochondria
and other organelles, maintaining healthier mother cells at themoment
when vegetative growth resumes. Another essential parameter is the
accumulation of stored nutrients, whose increase during CR is depen-
dent on mitochondrial respiration, particularly trehalose, as mentioned
earlier. Relevant to the connection between CLS andRLS, trehalose is not
only essential in enabling yeast cells to survive starvation conditions,but also in facilitating their rapid proliferation upon their return to
favorable growth conditions by fueling cell-cycle progression [65].
Together, the data available demonstrate that CR modulates a
common molecular mechanism linking mitotic and post-mitotic aging
in yeast. Notably, mitochondrial function plays a critical role in this
common aging mechanism.
2.4. Protein and amino acid restriction stimulate speciﬁc nutrient signaling
pathways to increase longevity
Basic research with the goal of understanding the effects of individ-
ual dietary components on cellular and organismal response has shown
that restriction of proteins (PR) or certain amino acids is themost effec-
tive single macromolecule restriction in the extension of longevity in
cellular and animal models and reduced incidence and/or progression
of multiple age-related diseases in mammals [25].
In the yeast S. cerevisiae, several nutrient-sensing pathways control
growth and aging, as mentioned earlier [15]. Whereas the TOR1–Sch9
pathway is primarily activated by amino acids, the Ras2–cAMP–PKA
pathway is stimulated predominantly by glucose [15]. Dietary restric-
tion, either CR or PR inhibits these pathways, resulting in enhanced
mitochondrial respiration, activation of the serine/threonine kinase
Rim15 and consequently the activity of stress-sensitive transcription
factors Msn2/Msn4 and Gis1, which control the expression of stress
resistance systems that postpone the effects of aging and extend
lifespan.
Like CR, amino acid restriction is sufﬁcient to extend yeast lifespan
[66,67]. Shortage of amino acids results in accumulation of uncharged
tRNAs and subsequent activation of the protein kinase GCN2, which
facilitates metabolic adaptation leading to slow growth [66], and inhibi-
tion of the TOR1–Sch9 pathway, leading to enhanced stress resistance.
Recent investigations have focused on identifying those speciﬁc amino
acids that particularly affect lifespan. Methionine restriction and
increased glutamic acid have both been shown to promote yeast
longevity. The effect of methionine restriction has been proposed to
be mediated by transsulfuration pathway (TSP)–dependent hydrogen
Fig. 2.Mammalian energy-sensing pathways implicated in dietary interventions. A complex crosstalk exists between the energy-sensing pathways in mammals. The complexes of the
mTOR pathway, TORC1 and TORC2 are activated by signals of high nutrient availability. TORC1 is stimulated by the presence of amino acids, growth factors including insulin, ATP, and
glycolysis metabolites. TORC2 is also activated by growth factor signaling including insulin and EGF and further activates TORC1 through Akt. Together, TORC1 and TORC2 stimulate
cell growth and proliferation through the inhibition of cell maintenance pathways such as autophagy, and the stimulation of global protein synthesis. Conversely, AMPK inhibits
TORC1 and is activated by a low energy status in the cell. AMPK also contributes activate the sirtuins, including SIRT1 and SIRT3, and is in turn further activated by SIRT1. SIRT1 leads
to the activation of PGC-1α. PGC-1α activation induces the transcription of many important genes involved in mitochondrial biogenesis and regulation, including Nrf-1, and Nrf-2,
which induce expression of TFAM, and also further transcriptionally activates itself and SIRT3. Meanwhile, SIRT3 activates FoxO3, which induces the expression of key ROS antioxidants
such as SOD2 and catalase as well as key genes involved in autophagy. SIRT1 further activates autophagic machinery by deacetylation of key atophagic components. Activation of autoph-
agy can consequently activate mitophagy, leading to selective clearance of damaged or unﬁt mitochondria. In the mitochondria, SIRT3 also deacetylates many proteins including com-
plexes of the electron transport chain, MPTP component cyclohpilin D, and SOD2, resulting in greater respiratory efﬁciency, apoptotic resistance, and ROS protection. Arrows indicate
activation. T bars indicate suppression.
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longevity through a recently discovered mechanism involving mito-
chondrial functions [68]. In a different screen, supplementation of serine
(through the Pkh1/2-Sch9 pathway), or threonine and valine (through
the Tor1-Sch9 pathway), caused a strong sensitization of cells to oxida-
tive stress in glucose-containing media, and promoted aging in these
conditions [67]. Finally, leucine catabolism generates acetic acid,
which can be converted to acetyl-CoA in mitochondria or the nucleus,
thus affecting both mitochondrial function and the acetylation state
of histones, and as a consequence, signiﬁcantly impacting cellular
longevity [67].
3. Dietary Restriction, Mitochondria, Aging and Longevity in Multi-
cellular Model Organisms
3.1. Conservation of dietary restriction-induced pathways in higher
eukaryotes
Studies in nematodes, ﬂies, and rodents have established the
evolutionary conservation of longevity factors and nutrient-sensing
pathways identiﬁed in yeast. Themolecular signaling pathwaysmediat-
ing the pro-health and anti-aging effect of DR in higher organisms
include the insulin and insulin-like growth factor-1 (IGF-1), TOR,
NAD+-dependent sirtuin deacetylase, AMP-activated protein kinase
(AMPK), PGC-1α and mitochondrial retrograde pathways, which form
an extensive, interacting network [15] (partially depicted in Fig. 2).
These pathways and their effect on regulating healthspan and lifespan
will be summarized in this section.
3.1.1. Insulin/IGF-1 signaling (IIS)
Different nutrients can activate different pathways directly or
indirectly. In yeast, glucose stimulates the Ras2-cAMP-PKA pathway,whose pro-aging effect is neutralized by CR [15]. In higher eukaryotes,
nutrients increase the level of insulin and IGF-1, which, in turn, activate
pro-aging pathways and play contributory roles in diseases of aging,
whereas CR counteracts their effects. The partial conservation and
differences of the glucose or insulin/IGF-I–like pathways from yeast to
mammals has been extensively reviewed [14]. In C. elegans, mutations
that inactivate the insulin/IGF-I pathway result in increased thermotol-
erance and antioxidant defenses as well as longevity. These effects re-
quire activation of a stress resistance factor, the forkhead transcription
factor Daf-16, which regulates the expression of a large number of
genes involved in xenobiotic metabolism and stress resistance [69].
Overexpression of Daf-16 in worms or an ortholog in ﬂies extends
lifespan [69,70]. In mammals, insulin and IGF-I bind to their respective
receptors triggering a cascade of events including activation of phos-
phatidylinositol 3-kinase (PI3K) and serine–threonine protein kinases
(Akt-1/Akt-2/protein kinase B [PKB]). FoxO family proteins are the
mammalian homologs of Daf-16. When nutrients are available, binding
of insulin or insulin-likemolecules to their respective receptors leads to
activation of PI3K and Akt and phosphorylation of Daf-16 in C. elegans
and FoxOs in mammals. Phosphorylated FoxO factors are transported
out of the nucleus. When insulin signaling is decreased (such as during
CR), FoxO expression and nuclear compartmentalization are both
increased, thus ensuring the buildup of robust anti-stress defenses.
Mutations in mammalian genes that downregulate IIS increase longev-
ity, such as in the case of dwarf mice, which harbor mutations in the
pituitary growth hormone (GH) receptor, involved in regulating IGF-I
release from the liver (reviewed in [14]). This lifespan extension effect
has been linked to that induced by CR, with partially overlappingmech-
anisms [71]. Similar to TOR, IIS activates the downstream effector S6K,
which plays a key role in the regulation of aging in worms and
mammals [17]. S6K1 knockout mice display ameliorated age-related
pathology and life span extension similar to those observed under CR.
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regulates the TOR pathway [17]. As discussed below, TOR kinase and
AMPK are major upstream regulators of mitochondrial metabolism, a
regulation that offers an essential contribution to mediate CR-induced
longevity [72]. Interestingly, dwarf mice have increased mitochondrial
respiration and increased metabolism per body weight, indicating that
decreased GH signaling may beneﬁcially affect mitochondrial ﬂexibility
by increasing the capacity for fat oxidation [73,74]. Similarly, fat-speciﬁc
insulin receptor knockout mice, which also have extended lifespan,
have increased expression of PGC-1α and PGC-1β, enhancedmitochon-
drial gene expression, and boosted oxidative metabolism in white
adipose tissue [75].
3.1.2. TOR signaling
First studied in yeast, the amino acid sensing TOR kinase pathway
also mediates DR-induced longevity in worms, ﬂies, and mammals.
Lifespan extension by inhibition of the TOR pathway is nutrient depen-
dent in both Drosophila [76] and yeast [56], establishing the role of TOR
in mediating the effects of DR. In yeast, as well as in mammalian cells,
TOR kinase exists in two separate multi-protein complexes, designated
TORC1 and TORC2, which have different biological functions. In mam-
mals, however, there is a single TOR gene that functions in both the
TORC1 and TORC2 complexes, while in S. cerevisiae there are two
distinct TOR kinase genes [77]. TORC1 induces protein synthesis and be-
comes active only when an adequate supply of amino acids is available
within the cell, particularly leucine [78]. TORC1 activity is stimulated by
signals of energy availability including ATP, insulin, and growth factor
signaling and is inhibited by signals of cellular stress including ROS, ER
stress, and hypoxia [77]. Dysregulation of TORC1 signaling plays a
major role in many cancers as well as many diseases associated with
aging [79]. Like TORC1, TORC2 is stimulated by the availability of nutri-
ents and growth factors, although through lesser-known mechanisms.
TORC2 functions as a key regulator of pathways involved in cytoskeletal
maintenance and growth as well as cellular metabolism [77]. Both
TORC1 and TORC2 inhibit autophagy, with TORC1 known to speciﬁcally
interact with the autophagy initiation complex [77,79]. Thus, it may be
assumed TOR signaling may also inhibit the selective degradation of
damaged mitochondria through mitophagy since both processes share
the same initiation mechanisms. Upstream activators of TORC1 include
the insulin/PI3K/Akt-signaling pathway, stimulated when circulating
insulin increases in response to high glucose availability. Activation of
the pathway leads to the phosphorylation and activation of Akt, which
ultimately leads to an increase in TORC1 through a release of inhibition.
Additionally, TORC1 can be activated by other growth factors, such as
epidermal growth factor (EGF), which signal through the Ras/MAPK/
ERK pathway [77]. Downstream targets of TORC1 include eukaryotic
translation initiation factor 4E-binding protein (4E-BP) and S6K, both
of which function to increase global protein synthesis. TORC2 activates
Akt, further stimulating TORC1 activity and inhibiting the activity of
FoxO3 [79]. The intricacies of TOR signaling have been extensively
reviewed [77,79].
Accumulating evidence suggests that TOR kinase can also regulate
mitochondrial mass and function in higher eukaryotes as it has been
observed in yeast, although the effects may be different. In Drosophila,
4EBP1 extends lifespan upon dietary restriction by translationally
upregulatingmitochondrial OXPHOS components speciﬁcally, therefore
enhancingmitochondrial activity, asmeasured inwhole animal homog-
enates [76]. Similar to what has been observed in yeast tor1 knockouts
[19], increased mitochondrial respiration upon TORC1 ablation (raptor
KO in adipose tissue) has also been seen in mice [80]. However,
TORC1 inhibition in mammalian cells appears to reduce mitochondrial
function, suggesting that TORC1 is important for maintenance of mito-
chondrial OXPHOS. Furthermore, mammalian TORC1 (mTORC1) ap-
pears to play a role at multiple levels to regulate mitochondrial
function. mTORC1 is involved in controlling mitochondrial biogenesis
through a yin-yang 1 (YY1)/PGC-1α transcriptional complex to balanceenergy metabolism through transcriptional control of mitochondrial
oxidative function [81]. mTORC1 is also involved in direct regulation
of mitochondrial activity via phosphorylation of speciﬁc proteins,
regulation of uptake and utilization of carbohydrates to balance glyco-
lytic ﬂux with mitochondrial respiration, and regulation of mitophagy
[82]. Maintenance of mitochondrial homeostasis involves feedback of
mitochondrial function on TORC1, in order to adjust mitochondrial
biogenesis to nutrient availability. In this respect, TORC1 activity is
regulated by ROS. Although many effects of ROS on TORC1 activity are
cell-type speciﬁc, they seem to be concentration dependent: TORC1 is
induced by low levels of ROS, while mid-range and high levels of ROS
inhibit TORC1 activity [82].
TORC2 could also play a distinct role linked to mitochondrial
function. Activated TORC2 has recently been found to localize to special-
ized areas of mitochondria-associated endoplasmic reticulum (ER)
membranes (MAMs), contributing to mitochondrial and ER calcium
release/uptake regulation, and therefore affecting apoptosis resistance
[83].
3.1.3. Sirtuins
Sirtuins are directly linked to nutrient and metabolic signaling
through their requirement of NAD+ as a cofactor. Sirtuins function as
crucial regulators of many protein post-translational modiﬁcations
within numerous cellular pathways, suggesting that sirtuinsmay be ca-
pable of conveyingwidespread functional changeswith altered nutrient
availability [84]. Support for sirtuins as possible mediators of the bene-
ﬁts of CR ﬁrst came from yeast, inwhich knockout of SIR2, the lone yeast
sirtuin gene, was found to eliminate lifespan extension by CR [85]. Addi-
tionally, overexpression of SIR2 orthologs has been shown to convey
lifespan extension in yeast, worms, ﬂies, and mice [84,86]. Mammals
possess seven sirtuin proteins (SIRT1-7) each with distinct cellular lo-
calizations and functions. Of these, nuclear- and cytoplasmic-localized
SIRT1 and mitochondrial-localized SIRT3 deacetylases have been most
extensively studied for their possible roles in the beneﬁts of CR [84].
For example, SIRT1 expression increases during CR in both mice and
humans and declines under high fat diet or obesity [86]. Studies in
mice have also shown that SIRT1 overexpression conveys similar bene-
ﬁcial health effects as CR and protects various markers of health upon
diet-, injury-, and disease-related stressors [84]. Protein pathways acti-
vated by SIRT1 deacetylation include PGC-1α-regulated mitochondrial
biogenesis, AMPK signaling, and autophagy, discussed in more detail
below and reviewed in [84]. Studies of SIRT1 overexpression have failed
to ﬁnd any signiﬁcant lifespan extension, suggesting that SIRT1 activity
may not be themajormediator of this beneﬁcial effect of CR. However, a
recent report has proposed that the age-dependent mitochondrial
OXPHOS activity decline observed inmouse skeletalmuscle is due to re-
duced SIRT1 activity, which induces alterations in expression of nuclear
genes including mitochondrial transcription factor A (TFAM) [87].
Intriguingly, although TFAM expression is known to be stimulated by
PGC-1α, the SIRT1-PGC-1α pathway is not involved in the mechanism
described. Rather, the mechanism involves SIRT1-dependent downreg-
ulation of the von Hippel-Landau protein (VHL), a negative regulator of
the hypoxia inducing factor alpha (HIF-1α), which is stabilized and in
turn inhibits the ability of c-Myc to activate the TFAM promoter [87].
Further veriﬁcation of this model is warranted. Additionally, the same
report showed that the age-dependent mitochondrial OXPHOS dys-
function, and several features of muscle pathology, could be reversed
by activating SIRT1 enzymatic activity via increasing NAD+ levels by
treatment with nicotinamide mononucleotide (NMN).
The mitochondrial deacetylase SIRT3 has been also shown to be
relevant to aging. Like SIRT1, increased activation of SIRT3 is seen after
multiple DR regimens and decreased SIRT3 activation occurs under
high fat diets [88]. Loss of SIRT3 results in robust mitochondrial protein
hyperacetylation [89], while CR induces deacetylation of awide range of
mitochondrial proteins [89]. Importantly, most of the mitochondrial
proteins with decreased acetylation after CR show hyperacetylation in
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post-translational modiﬁcation in mitochondria. Furthermore, changes
in mitochondrial protein acetylation following CR were much more ro-
bust than changes in the expression levels of mitochondrial proteins
[89], further supporting post-translational modiﬁcation through SIRT3
as a possible key mediator of CR effects. SIRT3-mediated protein
deacetylation has numerous effects on mitochondria. For example,
SIRT3 directly deacetylates complex I and II of the mitochondrial elec-
tron transport chain (ETC.), enhancing the activity of the complexes
and increasing ATP production [90]. Complex IV activity is also reduced
in the absence of SIRT3 [91]. Additionally, cellular ROS levels are regulat-
ed by SIRT3 with increased ROS levels upon SIRT3 inhibition, and re-
duced ROS levels with SIRT3 overexpression [91]. One mechanism
through which SIRT3 has been shown to reduce intracellular ROS is
through the deacetylation and activation of the forkhead transcription
factor FoxO3, which leads to the increased translation of antioxidant
proteins including SOD2, catalase, and peroxiredoxin III [92,93]. SIRT3
also deacetylates SOD2 directly leading to enhanced SOD2 enzymatic
activity and decreased intracellular ROS [94,95]. Additionally, mito-
chondrial apoptosis induction is inhibited by SIRT3 through the SIRT3-
mediated deacetylation of cychlophilin D, a key component of the
mitochondrial permeability transition pore (MPTP) [96]. Interest in
the role of SIRT3 in aging, DR, and mitochondrial function is likely to
grow in the future, since, in addition to the many known targets of
SIRT3 [97], manymore targets are likely to exist as themajority of mito-
chondrial proteins have recently been predicted to have acetylation
sites likely acted upon by SIRT3 [89].
3.1.4. AMPK
The AMPK energy-sensing pathway is highly conserved within
eukaryotes. The yeast AMPK homolog is Snf1 kinase, found as part of a
transcriptional complex (SNF1 complex) required for the transcription
of glucose-repressed genes. Essentially, yeast cells attain energy homeo-
stasis through complex regulatory events that are predominantly
controlled by Snf1 kinase. This major regulator senses stress and energy
starvation and responds by activating metabolic processes to produce
ATP and by inhibiting biosynthesis, thereby controlling the switch
between catabolism and anabolism [98]. Sfn1 plays an important role
in lifespan regulation. For example, constitutive genetic coactivation of
the mitochondrial RTG response and the Snf1 pathway reprograms
energymetabolism to increase the supply of acetyl-CoA to lysine acetyl-
transferases and extend the CLS of cells devoid of mitochondrial DNA
(ρ0 cells) [99]. Furthermore, enhanced Snf1 kinase activity by either
overexpression of SNF1 or through double-deletion mutants of the
SNF1 repressors Mig1 and Hxk2, signiﬁcantly curtails CLS. Similarly,
increased Snf1 activity, through deletion of repressor subunit SIP2 or
overexpression of the SNF1 gene, also decreases yeast RLS [100].
In C. elegans andDrosophila, overexpression ofwild-type or constitu-
tively active AMPK as well as AMPK upstream activators has been seen
to consistently extend lifespan [101]. AMPK promotes healthy aging in
part from its ability to integrate multiple signaling and transcriptional
pathways known to promote longevity. However, frequent feedback
regulationwithin the network creates a challenge in deﬁning important
linear pathway components. In contrast to the TOR signaling pathway,
AMPK is activatedwhen cellular energy stores become depleted, sensed
through minute increases in the AMP/ADP:ATP ratio. AMPK activation
then acts to restore cellular energy through the inhibition of energy-
consuming processes such as the synthesis of proteins, glycogen, and
fatty acids combinedwith the activation of energy-producing pathways
such as glucose uptake, glycolysis, and fatty acid β-oxidation [101]. In
accordance with the contrasting roles of AMPK and TOR activation,
there is considerable crosstalk between the two pathways. Activated
AMPK acts to inhibit TORC1 at multiple levels through direct as well
as upstream inhibition [77]. Additionally, S6K, a downstream target of
TORC1 has recently been found to phosphorylate and inactivate AMPK
[101] Therefore, inhibition of TORC1 can further enhance the activationof AMPK. Furthermore, AMPK activation also leads to an increase in au-
tophagy, while TORC1 and TORC2 are implicated in reduced autophagy.
On the other hand, AMPK has been shown to act in a positive feedback
loop with both SIRT1 and SIRT3 by increasing the NAD+:NADH ratio
[102], leading to sirtuin activation. Activation of both SIRT1 and SIRT3
then leads to the deacetylation and activation of the upstream activator
of AMPK, LKB1, resulting in increased AMPK activation [88]. SIRT1 and
AMPK further act together to activate PGC-1α through respective
deacetylation and phosphorylation [102,103], therefore regulating
mitochondrial biogenesis and cellular bioenergetics as explained
below. For a review of AMPK signaling, see [101].
3.1.5. PGC-1α
In metazoans, PGC-1α, considered the master regulator of mito-
chondrial biogenesis [24], belongs to a family of co-activators that
are activated by fundamental cellular signals that control energy and
nutrient homeostasis, such as cAMP and cytokine pathways [104].
PGC-1 s are not found in yeast, where mitochondrial biogenesis re-
quires two heme-regulated transcriptional activators, the Hap1 protein
and the HAP complex (Hap2/3/4/5) [105,106]. Whereas Hap1mediates
only the oxygen regulation of aerobic genes and its activity ismodulated
by heme binding [107], the HAP complexmediates the regulation in re-
sponse to both, oxygen concentration and carbon source availability,
and senses heme through its catalytic subunit (Hap4)[108]. The genes
regulated by the HAP complex are repressed by glucose even in
the presence of oxygen/heme [108]. During the diauxic shift, nuclear
genes involved in oxidative metabolism are de-repressed, resulting in
enhanced mitochondrial biogenesis. As explained earlier, HAP4 overex-
pression extends yeast RLS. Additionally, the HAP complex is also
activated during CR, thereby contributing to inducing RLS and CLS
extension. Mutations in hap1 also negatively affect CLS [7] .
In metazoans, once PGC-1α is activated, it induces and coordinates
gene expression regulating many metabolic and cell fate decisions,
including the stimulation of mitochondrial oxidative metabolism in
many tissues, ﬁber-type switching in skeletal muscle, and multiple
aspects of the fasting response in liver, among other functions [104].
PGC-1α achieves regulation through speciﬁc interaction with a variety
of transcription factors, including nuclear respiratory factors NRF1 and
NRf2, which stimulate genes associated with oxidative metabolic path-
ways [109] including those genes involved in mitochondrial respiration
and mitochondrial DNA expression. The control of mitochondrial
biogenesis by PGC-1α, initially observed in brown fat has been observed
inmost tissues, including skeletalmuscle and brain [109]. PGC-1α andβ
are induced by oxidative stress and the ability of ROS to induce a ROS
scavenging program (includingmitochondrial SOD2 aswell as cytoplas-
mic proteins such as catalase and GPX1) depends on the PGC-1 s. Cells
lacking PGC-1α are hypersensitive to oxidative stress. Mice deﬁcient
in PGC-1α are viable but have a marked reduction in the mRNA levels
of genes coding for mitochondrial proteins in all tissues examined.
These mice undergo excessive neurodegeneration when given pharma-
cological agents that cause Parkinsonism. These data show that the
PGC-1 s are not only key modulators of mitochondrial biology but also
important protective molecules against ROS generation and damage
[109].
The role of PGC-1α in CR and other models of longevity has been re-
cently reviewed [110] and was discussed as a target of the different
pathways mentioned earlier. An important question is whether en-
hancement of mitochondrial biogenesis in a PGC-1α-mediated manner
is sufﬁcient to extend healthspan and lifespan. In this regard, enhanced
mitochondrial homeostasis mediated by tissue-speciﬁc overexpression
of Drosophila PGC-1α is sufﬁcient to extend lifespan in ﬂies [111].
Importantly, while ubiquitous PGC-1α overexpression enhanced mito-
chondrial biogenesis and induced accumulation of glycogen, it also
moderately shortened lifespan, suggesting that these outcomes might
have adverse effects in select tissues. On the contrary, enhancing PGC-
1α speciﬁcally in intestinal stem cells enhanced coupled mitochondrial
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tissue, leading to improved tissuemaintenance and promoting organis-
mal longevity [111]. These studies are reminiscent of the observations
made in yeast, where HAP4 overexpression extends RLS lifespan but
not CLS. In mammals, PGC-1α levels have been shown to decline with
age, and to be restored byCR [112]. Overexpression of PGC-1αhas prov-
en to be beneﬁcial in some mouse models of Huntington’s disease and
other neuromuscular degenerative diseases [113]. However, although
moderate enhancement of mitochondrial biogenesis can be beneﬁcial
in some disease scenarios, it has not been shown to extend longevity.
Furthermore, excessive PGC-1α levels can be deleterious in some
tissues such as skeletal muscle or heart, indicating that mitochondrial
biogenesis needs to be carefully adjusted, perhaps as it occurs during
CR, to achieve the desired health beneﬁts [114].
3.1.6. Mitochondrial retrograde pathways
The originally described yeast mitochondrial-to-nucleus RTG signal-
ing pathway does not seem to be exactly conserved in higher eukary-
otes, although it has been demonstrated in yeast crosstalk between
the retrograde response and the conserved TOR1 and RAS-cAMP-PKA
signaling pathways, both of which are key players in yeast RLS and
CLS and also in metazoan aging [40].
Furthermore, a variety of mitochondrial retrograde signaling
processes (broadly deﬁned as signaling from the mitochondria to the
rest of the cell) have been identiﬁed in yeast and higher eukaryotes
(reviewed in [115]), some of which will be brieﬂy discussed here. CR,
inhibition of IGF1 signaling, and inhibition of TOR signaling promote
longevity at least in part by eliciting mitochondrial retrograde signaling
processes. From yeast to human, these pro-longevity interventions
enhance mitochondrial respiration and consequently mitochondrial
ROS production. ROS can act as adaptive signalingmolecules by activat-
ing pathways that promote cellular resistance to various stresses, as
explained earlier for yeast tor1mutants [21]. These observations align
with the concept of “mitohormesis”, in which low-levels of stressors,
for example during DR, (i.e. reactive oxygen and nitrogen species due
to enhanced overall mitochondrial OXPHOS activity and/or mitochon-
drial fatty acid oxidation) promote adaptive changes resulting in stress
resistance [5]. The reader is directed to a full article in this BBA Special
Issue, dedicated to “mitohormesis” (REF).
Mitochondrial stress, mitonuclear protein imbalance, and general
loss of mitochondrial ﬁtness also trigger the mitochondria-speciﬁc
unfolded protein response (UPRmt) [116,117], a mitochondria-nuclear
signaling pathway that induces the expression of mitochondria-
protective molecular chaperones and other regulators of mitochondria
homeostasis. In C. elegans, the UPRmt signiﬁcantly contributes to the
transduction of mitochondrial respiratory chain alteration based exten-
sion of lifespan [118]. Interventions such as CR and inhibition of TOR
signaling generate mitonuclear imbalance and therefore also elicit the
UPRmt, which contributes to longevity mechanisms [119]. A full article
in this BBA special issue is dedicated to the UPRmt, how it is activated,
and crosstalks with other anti-stress pathways to afford cytoprotection
in the context of organismal aging [120].
The effects ofmitochondrial retrograde signalingmay even spread to
other cells/tissues in a cell-non-autonomous manner by yet unidenti-
ﬁed signaling mediators that have been termed “mitokines” [118].
These mitokines could then, in theory, help coordinate the cellular
metabolic state and longevity of the entire organism. UPRmt has
additionally been implicated in this signaling mechanism in C. elegans,
as mitochondrial functional deﬁcits in neuronal cells have been seen
to activate UPRmt in distal intestinal tissue [118].
An emerging new class of mitochondrial signals capable of regulat-
ing aging and lifespan are the mitochondrial-derived peptides (MDPs),
encoded by functional short open reading frames (sORFs) in the
mtDNA [121]. Among them, Humanin (HN) is a recently identiﬁed
neuroprotective and antiapoptotic peptide derived from a portion of
the mitochondrial 16S ribosomal RNA, MT-RNR2 gene [122]. HN isfound in both tissues and plasma and has been seen to decline with
age in both rats in humans, suggesting that this small peptide may
play a role in longevity [123,124]. Similarly, MOTS-c is a MDP derived
from the open reading frame of the mitochondrial 12S RNA that has
been found to be able to systemically alter metabolism through down-
stream effects on the AMPK signaling pathway [125]. However, despite
these recent advances, the mechanisms of mitochondrial retrograde
signaling in multicellular organisms remains to be fully understood.
3.2. DR mimetics, aging, and mitochondria
Studies on the molecular mechanisms underlying the beneﬁcial
effects of DR have identiﬁed targets for natural or pharmacological
interventions that could reproduce the beneﬁcial effects in humans
without the necessity to comply with a rigorous dietary program,
particularly late in life. Likely candidates act on the same signaling path-
ways as DR, and include resveratrol and other polyphenols, rapamycin,
insulin and AMPK pathway activators, autophagy stimulators, alpha-
lipoic acid, and perhaps other antioxidants. Studies on some of these
interventions are discussed below.
3.2.1. Sirtuin activators
Produced by grapes, berries, and peanuts and found in relatively
high concentrations in red wine, the natural polyphenol resveratrol
gained widespread interest as a possible mediator of numerous beneﬁ-
cial health effects including a reduced risk for cancer and cardiovascular
disease and improvements in metabolic ﬁtness in mice and monkeys
fed a high-fat diet (reviewed in [126]). Resveratrol also increases
lifespan in C. elegans and Drosophila, although the robustness of these
effects has been questioned [126]. Resveratrol was ﬁrst found, however,
to be able to extend RLS in yeast. It was proposed to act through the
same mechanism as CR, by activating Sir2 [127]. However, the involve-
ment of Sir2 in the mechanism of action of resveratrol has been
challenged [128] and it has been suggested that the physiological effects
of resveratrol could be mediated by alternative targets. In mice, recent
data suggests that the mechanism of action of resveratrol could be
dose-dependent. Accordingly, resveratrol may act through SIRT1 only
at low doses but may also activate AMPK across concentrations to
produce beneﬁcial effects on mitochondrial function though activation
of PGC-1α and subsequent enhancement of mitochondrial biogenesis,
oxidative phosphorylation, and fatty acid oxidation [129]. In addition,
frequent feedback loops exist among these pathways, with SIRT1
being able to activate AMPK and therefore activate the same down-
stream effects [129].
3.2.2. TOR inhibitors
Rapamycin, an inhibitor of TOR signaling across species, is a robust
DR mimetic. Rapamycin has been shown to consistently increase
lifespan in many model organisms from yeast to mammals (reviewed
in [130]). In yeast, rapamycin induces comparable effects on mitochon-
drial function and longevity as the tor1 null mutation.While rapamycin
does not seem to enhance mitochondrial biogenesis, rapamycin in-
creases the density of OXPHOS complexes and increases coupled respi-
ration and ROS during growth, preconditioning the cell and ultimately
leading to CLS extension. In Drosophila, rapamycin increases mitochon-
drial oxidative capacity while simultaneously reducing mitochondrial
ROS production, similar to what is seen in CR [131]. In mammals,
rapamycin is a potent inhibitor of TORC1, and also of TORC2 at high
doses or chronic treatments [132]. Rapamycin treatment drastically
attenuates the detrimental effects of both high protein and high fat
diets in mice [133]. Speciﬁcally, in mice a signiﬁcant decrease in the
amount and function of muscle mitochondria was seen following a
life-long high-protein diet, which was reverted by chronic treatment
with rapamycin [133]. Inhibition of mTOR by rapamycin also activates
selective degradation of unﬁt mitochondria through mitophagy, a pro-
cess critical for mitochondrial quality control. Mitophagy is essential
Fig. 3. DR-induced alterations in mammalian mitochondrial function implicated in longevity extension. Representation of mitochondrial-functional alterations that are most conserved
across dietary interventions in mammals in which increased health or longevity has been reported.
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genomes carrying OXPHOS-disabling mutations [134].
3.2.3. AMPK agonists
Many classical agonists activate AMPK indirectly by altering the AMP/
ADP:ATP balance in the cell and act as DR mimetics. The list includes
5-aminoimidazole-4-carboxamide-1-D-ribo-furanoside (AICAR), which
cells convert to an AMP analog (ZMP), and metformin, a mitochondrial
respiratory chain complex I inhibitor. Although these compounds can
promote longevity in some settings, particularly in C. elegans and mice,
conﬂicting results have been reported in other model organisms. In
mice, AICAR induces a PGC-1α-mediated increase in mitochondrial
biogenesis and a 4-week treatment of AICAR can confer comparable
beneﬁts as endurance training to sedentary mice in terms of both mus-
cle mitochondrial proﬁles and actual treadmill endurance (reviewed in
[101]). Regarding metformin, several reports suggest similarities
between its actions and the effects of CR. As such, microarray analyses
have shown that metformin induces a gene expression proﬁle that
overlaps more than 85% with that of DR [135]. In mammals, the beneﬁ-
cial effect of metformin on health (diabetes and cancer in human) is
more established than its effects on longevity [101]. However, although
research is advancing on the physiological beneﬁts of metformin, its
exact molecular target/s remain to be fully identiﬁed. The proposed tar-
gets include activation of mitochondrial respiratory chain complex I,
AMPK, and SIRT1. In addition, metformin has recently been reported
to inhibit mTOR, thereby suggesting a potential overlap in the signaling
pathways induced by both metformin and rapamycin [101].
3.3. Conservation of mitochondrial mechanisms of dietary restriction-
induced extension of healthspan and lifespan
As in yeast, mitochondrial function declines during aging in higher
eukaryotes from worms to mammals, including humans (reviewed in
[72]). The mitochondrial alterations affect morphology, mitochondrial
mass,mitochondrial DNA (mtDNA) copy number, and OXPHOS enzyme
function (Fig. 3), sometimes in a tissue-dependent manner. Most of
these alterations are prevented by DR regimes. In this section we will
brieﬂy discuss the mitochondria-mediated effects of DR on health,
aging, and longevity of higher organisms.
3.3.1. Mitochondrial biogenesis
As explained in the previous section, several of the pathways
believed to be responsible for the beneﬁcial effects of DR lead to the ac-
tivation of PGC-1α and the consequent enhancement of mitochondrialbiogenesis. However, it remains a very controversial issue whether or
not DR itself leads to increased mitochondrial biogenesis through the
activation of PGC-1α, particularly in mammals. A report indicated that
30% calorie restriction (food provided in alternate days) for either 3 or
12 months in 8-month-old male mice raised nitric oxide (NO) levels
in liver, muscle, and brain. This increase in NO levels was found to be
the mediator of enhanced SIRT1 expression and PGC-1α activation
resulting in increased mitochondrial biogenesis, oxygen consumption,
and ATP production in these tissues. [9]. In the same line, primary hepa-
tocytes from 12-month-old rats fed 40% CR since weaning also had
increased SIRT1 leading to boosted stress resistance, and enhanced
PGC-1α activation leading to increased mitochondrial biogenesis and
improved bioenergetics [112]. In this study, CR was found to produce
very efﬁcient mitochondrial electron transport based on low-potential
mitochondria that sustain reduced oxygen consumption while main-
taining cellular ATP levels and reducing ROS production [112]. Further-
more, a decline in mtDNA content and mitochondrial transcription
factor A (TFAM) protein levels with age has been observed in several
mice tissues, in most of which the depletion is completely prevented
by CR [136], although it was not reported whether overall mitochondri-
al biogenesis had been enhanced. However, new reports question
whether CR truly increases mitochondrial biogenesis. The increased
mitochondrial mass observed in response to 30% CR in mice was not
detected in similar studies in rats [137], nor in 40% CR mice in which
PGC-1αmRNA levels increased without a concordant increase in PGC-
1α protein levels or mitochondrial protein synthesis [138]. Adding to
this line of observations, it was reported that chronic CR in mice
preserves mitochondrial function in senescence without increasing
mitochondrial biogenesis, as shown by transcriptome and functional
analyses, but by enhanced mitochondrial efﬁciency, decreased mito-
chondrial oxidant generation, and upregulated antioxidant defenses
[139]. Combined, these studies indicate that independently of the
mechanism involved, CR preserves mitochondrial content and function.
To reconcile the different results on mitochondrial biogenesis, the
possibility exists that CR-activated PGC-1α signaling may be tissue-
speciﬁc. In fact, a recent report proposed that PGC-1α does not neces-
sarily regulate basal mitochondrial biogenesis, but rather is involved
in increasing OXPHOS enzyme density and mitochondrial function
when required, by activating the expression of certain nuclear genes
in a tissue-dependent manner [140].
3.3.2. Respiratory efﬁciency and ROS generation
Despite the controversy regarding CR-mediated enhancement of
mitochondrial biogenesis, it seems widely accepted that CR improves
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ly, several studies [141] have shown that long term CR decreases meta-
bolic rate in rodents as it does during yeast CLS, thus furtherminimizing
ROS generation. Accordingly, CR mice have lower levels of oxidized and
deamidated proteins and of oxidatively damaged DNA [139]. Upregula-
tion of antioxidant defenses [139], as part of the overall upregulation of
cellular and molecular defense systems during CR, also accounts for CR-
induced reduction of intracellular ROS. In yeast and ﬂies, CR enhances
the levels of catalase and SOD2. Also in mice, CR prevents the decline
of these enzymes and peroxiredoxin III with age, although some
tissue-dependent variations have been observed [136,139]. Interesting-
ly, a study evaluating the effects of 20% CR in humans found signiﬁcantly
reduced oxidative DNA and RNAdamage inwhite blood cells, indicating
that ROS levels may also decrease in humans under CR [142].
3.3.3. Respiratory thresholds
Energy and respiratory thresholds have been described in human
mitochondrial physiology and disease as respiratory enzymes can be
inhibited to varying degrees before observing an OXPHOS phenotype
[143]. Respiratory thresholds to support cellular life probably vary for
every tissue, most likely altering the importance of other factors, like
ROS signaling, in a tissue-speciﬁc manner. Respiratory deﬁciencies are
associatedwith aging and age-related disorders [72]. Thus it is tempting
to speculate that interventions mimicking CR (or modulating nutrient
sensing pathways) might lower the energetic thresholds of critical,
affected tissues which, if accompanied by an enhancement of cellular
protection systems, could extend healthspan in normal and diseased
individuals suffering from age-associated disorders.
3.3.4. Nutrient stores
Accumulation and efﬁcient mobilization of nutrient stores, one of
the hallmarks of yeast CLS, and dependent on mitochondrial functions
as explained earlier, is also relevant to stress responses across species.
Throughout the course of evolution, factors such as limiting resource
availability were most likely instrumental in driving adaptations that,
among other effects, were capable of enhancing survival during periods
of environmental pressure by impinging upon behavior and metabolic
changes that improved survivability. While yeast cells accumulate car-
bohydrates (glycogen/trehalose), mammals can accumulate glycogen
and increase fat mass as a stress response to the uncertainty of food
availability. Therefore, a conserved response to starvation stress is to
accumulate carbon sources that would maximize long-term survival
and to utilize them efﬁciently later in life [6]. Worth mentioning, one
of the effects of CR in mammals is the elevation of liver insulin sensitiv-
ity by the hormone adiponectin,which lowers endogenous glucose pro-
duction, diminishes reliance on glucose and its metabolites for energy,
and raises fatty acid oxidation [144]. This switch in substrate utilization
can reduce ROS generation atmitochondrial respiratory chain complex I
and therefore, minimize oxidative stress. Although it is tempting to
speculate that stimulating fatty acid utilization could increase longevity,
thismay be true only under CR. In fact, high fat diets and dependence on
fatty acid oxidation for production of energy by themitochondria drives
insulin resistance, diabetes, and cardiovascular disease [144].
3.4. Conservation of longevity pathway selectivity to respond to different di-
etary restriction regimens
Accumulating data in animal models as well as in humans suggest
that, as in yeast, not only CR but also restriction or supplementation of
individual dietary nutrients may have beneﬁcial effects on health- and
lifespan (reviewed in [23,25]). As an example, in this section we will
summarize the current knowledge on the contribution of protein and
amino-acid restriction to the beneﬁcial effects of DR regimes and will
highlight the emerging signiﬁcance of mitochondrial functions on the
mechanisms involved.Studies in worms have linked protein and amino acid intake to
activation of pro-aging and disease-promoting pathways and have
highlighted the beneﬁcial effects of diets restricting these nutrients.
For example, as in yeast, GCN2, the evolutionarily conserved kinase
responsive to amino acid deﬁciency, mediates lifespan extension
under DR conditions by converging on TOR/S6K signaling via FoxA
transcription factors and downstream target genes [145]. In another ex-
ample, AMPK/Aak-2 and the forkhead transcription factor FoxO/Daf-16
are necessary for longevity induced by a particular low-protein PR reg-
imen (dilution of peptone, a protein source) [146]. Studies in Drosophila
have highlighted the relevance of the ratio between proteins and carbo-
hydrates (P/C) on determining longevity, with lower P/C ratios (1/16)
extending lifespan [147] in a TOR signaling-dependent manner. As a
result of TORC1 inhibition, amino acid restriction in ﬂies resulted in
overall reduction in relative intracellular translation rate but an increase
in the translation of genes involved in importantmitochondrial process-
es, such as OXPHOS enzyme subunits and mitoribosomal proteins,
which led to an overall increase in OXPHOS activity [76]. These changes
were proposed to be dependent on an up-regulation of the translational
repressor, 4EBP as the changes in mitochondrial protein synthesis
occurred post-transcriptionally [76]. These results on a TORC1-4EBP
axis are consistent with previous studies in ﬂies [77] and are reminis-
cent of the observations made in yeast tor1 knockouts which have
decreased global translation but increased mitochondrial respiration.
As in ﬂies, a study that examined 25 different diets with various ratios
of protein, fat, carbohydrate, and energy contents found that mice on
diets with the lowest P/C ratio achieved the longest median lifespan
independent of calorie intake [148].
However, not all amino acids exert the same effect. In ﬂies, restric-
tion of essential amino acids, and in particular methionine, confers
most DR longevity beneﬁts [149], similar to what it has been observed
in yeast. In rodents, diets lacking the nonessential amino acid cysteine
and restricted for methionine also extend longevity by lowering serum
levels of IGF-I, insulin, and glucose and promoting resistance to oxida-
tive stress [150]. Methionine restriction inmice has been reported to in-
crease mitochondrial ATP production efﬁciency, to reduce electron leak
through respiratory chain complex I, and to decrease mtDNA damage
and protein oxidation [151]. Based on the observations that restriction
of sulfur amino acids (methionine and cysteine) is common to numer-
ous DR regimens across model organisms, that the transsulfuration
pathway (TSP) controls the conversion of methionine into cysteine
and is required for DR-mediated lifespan extension in ﬂies, and that hy-
drogen sulﬁde (H2S) supplementation extends the lifespan of worms, it
was recently hypothesized that H2S could mediate the physiological
beneﬁts of methione/cysteine restriction, including stress resistance
and extended longevity [68]. This study demonstrated that in mice, DR
stimulates endogenous H2S production via repression of mTORC1 and
activation of the TSP pathway and that H2S Is necessary and sufﬁ-
cient to confer DR-mediated stress resistance in vivo, which was ab-
rogated by administration of the antioxidant N-acetyl-cysteine [68].
TSP-dependent H2S production was observed in yeast, worm, fruit
ﬂy, and rodent models of DR-mediated longevity. Further studies
in vitro showed that cytoprotective effects of H2S during ischemia re-
quire sulfhydration of mitochondrial sulﬁde-quinone-reductase (SQR),
which allows transfer of electrons from H2S to coenzyme Q and themi-
tochondrial respiratory chain [68], thus establishing a new link between
mitochondrial functions and the health and longevity beneﬁts exerted
by DR interventions.
These studies on the beneﬁcial effects of mild increase of H2S bring
about the concept of “mitohormesis” [5] described earlier.
3.5. DR, mitochondria and aging in humans
To gain insight into the ability of CR to delay aging in humans, sever-
al studies have been conducted on non-human primates. However, the
conclusions from these studies, performed in rhesus monkeys, were
1444 A. Ruetenik, A. Barrientos / Biochimica et Biophysica Acta 1847 (2015) 1434–1447conﬂicting, most likely due to differing control group diets. In one study,
CR increased the average age of mortality, and was associated with the
prevention of hyperinsulinemia and the mitigation of age-related
diseases in comparison with ad-libitum fed animals [152]. In a parallel
study, improvements in the health of CR animals were apparent but
did not reach signiﬁcance (P=0.06), and survival was not signiﬁcantly
different between control-fed and CR monkeys [153]. Looking back, a
comparison of control animal body weight from both studies suggests
that the diet imposed to the control monkeys in the second study was
effectively already CR. The combination of these data indicate that the
beneﬁts of CR on health and aging are actually conserved in primates
[154], but moderate CRmay not be enough to confer longevity beneﬁts
compared to more severe CR.
The effects of CR in human health have also been investigated.
The CALERIE (Comprehensive Assessment of the Long-term Effects
of Reducing Energy Intake) multicenter study focused on the effects
of short-term CR. The results obtained so far are promising. CR im-
plemented for 6–12 months on moderately overweight individuals
resulted not only in weight loss, but also enhanced glucose tolerance
and insulin sensitivity, decreased metabolic rate, and improved
serum indicators of disease risk [155]. These studies also showed
that short term, 6-month CR (10% or 30%) induced increased levels
of plasma glutathione peroxidase activity (p = 0.04) and decreased
plasma protein carbonyl levels (p = 0.02), although no signiﬁcant
change was observed in other plasma antioxidants such as SOD and
catalase. These ﬁndings indicate that CR can modulate antioxidant
defense and oxidative stress in humans [156]. Beneﬁcial effects of
long-term CR on disease risk in humans have also been reported in
studies involving members of the Caloric Restriction Society who
voluntarily engage in the practice of CR. In these individuals, insulin
sensitivity is enhanced and levels of adiponectin are increased [157],
suggesting an increase in mitochondrial fatty acid oxidation as
reported in mouse models.
The currently available data indicates that a lifestyle modiﬁcation in
the form of CR, even if started during adulthood, can help to minimize
the risk of age-associated disorders and promote healthy aging in
humans, probably through molecular mechanisms largely conserved
along evolution.4. Conclusions and Future Perspectives
Despite the discoveries made in the ﬁeld of dietary research, many
questions remain. Studies of the yeast S. cerevisiae and other model
organisms have allowed for the identiﬁcation of conserved pathways
that control healthspan and lifespan in response to nutrient availability.
These studies have identiﬁed mitochondria as essential organelles,
contributors and targets of these pathways, orchestrating health-
promoting and longevity-deﬁning processes beyond the postulates
deﬁned by the free radical theory of aging. The DR-mediated effects
leading tomitohormesis, enhancedmitochondrial biogenesis, increased
OXPHOS efﬁciency, and improved mitochondrial quality control, to
name a few, as well as the involvement of mitochondrial retrograde
pathways, will require further mechanistic investigations. Although
further investigations in human populations are required, overall, how-
ever, it is becoming apparent that DR-mediated preservation of mito-
chondrial functions is fundamental to delay the onset of age-related
diseases and perhaps extend the average rate of mortality in humans
as it does across evolutionary boundaries, from yeast to non-human
primates.Transparency Document
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